Thomas A. Comery
About
Thomas A. Comery is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience.
According to data from OpenAlex, Thomas A. Comery has authored 40 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Pharmacology and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Thomas A. Comery's work include Cholinesterase and Neurodegenerative Diseases (14 papers), Neuroscience and Neuropharmacology Research (12 papers) and Receptor Mechanisms and Signaling (11 papers). Thomas A. Comery is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (14 papers), Neuroscience and Neuropharmacology Research (12 papers) and Receptor Mechanisms and Signaling (11 papers). Thomas A. Comery collaborates with scholars based in United States, Canada and Italy. Thomas A. Comery's co-authors include William T. Greenough, Scott A. Irwin, Ivan Jeanne Weiler, Patrick J. Willems, Ben A. Oostra, Mark R. Bowlby, Jeffrey A. Kleim, Menelas N. Pangalos, J. Steven Jacobsen and Robert Martone and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuron and Journal of Neuroscience.
In The Last Decade
Thomas A. Comery
39 papers receiving 4.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Thomas A. Comery United States | 20 | 2.1k | 1.5k | 1.2k | 1.2k | 1.1k | 40 | 4.6k | ||
| Jinsoo Seo South Korea | 29 | 3.0k 1.4× | 1.5k 1.0× | 1.0k 0.9× | 834 0.7× | 888 0.8× | 71 | 5.3k | ||
| Warren D. Hirst United States | 46 | 2.5k 1.2× | 2.5k 1.7× | 1.2k 1.0× | 370 0.3× | 587 0.5× | 90 | 5.9k | ||
| Xiaoning Bi United States | 43 | 2.0k 0.9× | 2.1k 1.4× | 959 0.8× | 671 0.6× | 424 0.4× | 102 | 4.7k | ||
| Anis Contractor United States | 35 | 2.2k 1.0× | 3.0k 2.0× | 614 0.5× | 933 0.8× | 1.4k 1.2× | 66 | 4.7k | ||
| Qiang Zhou China | 27 | 3.1k 1.5× | 4.9k 3.2× | 666 0.5× | 735 0.6× | 1.6k 1.4× | 69 | 7.0k | ||
| Lori L. McMahon United States | 34 | 1.5k 0.7× | 1.8k 1.2× | 481 0.4× | 531 0.5× | 674 0.6× | 80 | 3.4k | ||
| Farahnaz Sananbenesi Germany | 26 | 3.1k 1.5× | 1.3k 0.9× | 1.2k 1.0× | 1.1k 0.9× | 653 0.6× | 37 | 5.4k | ||
| Francesco Impagnatiello United States | 31 | 1.7k 0.8× | 1.8k 1.2× | 479 0.4× | 618 0.5× | 554 0.5× | 51 | 4.4k | ||
| Coleen M. Atkins United States | 32 | 2.5k 1.2× | 2.2k 1.5× | 536 0.4× | 765 0.7× | 1.1k 0.9× | 57 | 5.1k | ||
| Hiroshi Ujike Japan | 44 | 3.1k 1.5× | 3.7k 2.4× | 723 0.6× | 900 0.8× | 629 0.6× | 208 | 6.4k |
Countries citing papers authored by Thomas A. Comery
Since
Specialization
Citations
This map shows the geographic impact of Thomas A. Comery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Comery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Comery more than expected).
Fields of papers citing papers by Thomas A. Comery
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Thomas A. Comery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Comery. The network helps show where Thomas A. Comery may publish in the future.
Co-authorship network of co-authors of Thomas A. Comery
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Comery. A scholar is included among the top collaborators of Thomas A. Comery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Comery. Thomas A. Comery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Sawant‐Basak, Aarti, R. Scott Obach, Angela C. Doran, et al.. (2018). Metabolism of a 5HT6 Antagonist, 2-Methyl-1-(Phenylsulfonyl)-4-(Piperazin-1-yl)-1H-Benzo[d]imidazole (SAM-760): Impact of Sulfonamide Metabolism on Diminution of a Ketoconazole-Mediated Clinical Drug-Drug Interaction. Drug Metabolism and Disposition. 46(7). 934–942.
2.
Rosenzweig‐Lipson, Sharon, Thomas A. Comery, Karen L. Marquis, Jonathan Groß, & John Dunlop. (2012). 5-HT2C Agonists as Therapeutics for the Treatment of Schizophrenia. Handbook of experimental pharmacology. 147–165.
3.
Marquis, Karen L., Thomas A. Comery, Flora Jow, et al.. (2011). Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914/SEN34625. Psychopharmacology. 218(4). 635–647.
4.
Liu, Kevin G., Albert J. Robichaud, James F. Mattes, et al.. (2010). Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT6 antagonists. Bioorganic & Medicinal Chemistry. 19(1). 650–662.
5.
Haydar, Simon N., Chiara Ghiron, Laura Bettinetti, et al.. (2009). SAR and biological evaluation of SEN12333/WAY-317538: Novel alpha 7 nicotinic acetylcholine receptor agonist. Bioorganic & Medicinal Chemistry. 17(14). 5247–5258.
6.
Roncarati, Renza, Carla Scali, Thomas A. Comery, et al.. (2009). Procognitive and Neuroprotective Activity of a Novel α7 Nicotinic Acetylcholine Receptor Agonist for Treatment of Neurodegenerative and Cognitive Disorders. Journal of Pharmacology and Experimental Therapeutics. 329(2). 459–468.
7.
Kelly, Michy P., Sheree F. Logue, Jason M. Dwyer, et al.. (2009). The supra-additive hyperactivity caused by an amphetamine–chlordiazepoxide mixture exhibits an inverted-U dose response: Negative implications for the use of a model in screening for mood stabilizers. Pharmacology Biochemistry and Behavior. 92(4). 649–654.
8.
Liu, Kevin G., Thomas A. Comery, Dianne Kowal, et al.. (2009). Identification of a novel series of 3-piperidinyl-5-sulfonylindazoles as potent 5-HT6 ligands. Bioorganic & Medicinal Chemistry Letters. 19(12). 3214–3216.
9.
Leiser, Steven C., Mark R. Bowlby, Thomas A. Comery, & John Dunlop. (2009). A cog in cognition: How the α7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits. Pharmacology & Therapeutics. 122(3). 302–311.
10.
Grauer, Steven M., Virginia Pulito, Rachel L. Navarra, et al.. (2009). Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia. Journal of Pharmacology and Experimental Therapeutics. 331(2). 574–590.
11.
Liu, Kevin G., Thomas A. Comery, Dianne Kowal, et al.. (2009). Identification of a series of benzoxazoles as potent 5-HT6 ligands. Bioorganic & Medicinal Chemistry Letters. 19(4). 1115–1117.
12.
Jiang, Qingguang, Shweta Mandrekar, Brandy Wilkinson, et al.. (2008). ApoE Promotes the Proteolytic Degradation of Aβ. Neuron. 58(5). 681–693.
13.
Grauer, Steven M., Radka Graf, Rachel L. Navarra, et al.. (2008). WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics. Psychopharmacology. 204(1). 37–48.
14.
Dunlop, John, Brian Jow, Steven M. Grauer, et al.. (2008). Old and New Pharmacology: Positive Allosteric Modulation of the α7 Nicotinic Acetylcholine Receptor by the 5-Hydroxytryptamine2B/C Receptor Antagonist SB-206553 (3,5-Dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b′]di pyrrole-1(2 H)-carboxamide). Journal of Pharmacology and Experimental Therapeutics. 328(3). 766–776.
15.
Navarra, Rachel L., Radka Graf, Youping Huang, et al.. (2007). Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(1). 34–41.
16.
Comery, Thomas A., Robert Martone, Suzan Aschmies, et al.. (2005). Acute γ-Secretase Inhibition Improves Contextual Fear Conditioning in the Tg2576 Mouse Model of Alzheimer's Disease. Journal of Neuroscience. 25(39). 8898–8902.
17.
Weiler, Ivan Jeanne, Scott A. Irwin, Anna Y. Klintsova, et al.. (1997). Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proceedings of the National Academy of Sciences. 94(10). 5395–5400.
18.
Kleim, Jeffrey A., et al.. (1996). Synaptogenesis and FOS Expression in the Motor Cortex of the Adult Rat after Motor Skill Learning. Journal of Neuroscience. 16(14). 4529–4535.
19.
Comery, Thomas A., et al.. (1996). Increased Density of Multiple-Head Dendritic Spines on Medium-Sized Spiny Neurons of the Striatum in Rats Reared in a Complex Environment. Neurobiology of Learning and Memory. 66(2). 93–96.
20.
Comery, Thomas A., Rachna Shah, & William T. Greenough. (1995). Differential Rearing Alters Spine Density on Medium-Sized Spiny Neurons in the Rat Corpus Striatum: Evidence for Association of Morphological Plasticity with Early Response Gene Expression. Neurobiology of Learning and Memory. 63(3). 217–219.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jinsoo Seo Breakdown of academic impact, for papers by Warren D. Hirst Breakdown of academic impact, for papers by Xiaoning Bi Breakdown of academic impact, for papers by Anis Contractor Breakdown of academic impact, for papers by Qiang Zhou Breakdown of academic impact, for papers by Lori L. McMahon Breakdown of academic impact, for papers by Farahnaz Sananbenesi Breakdown of academic impact, for papers by Francesco Impagnatiello Breakdown of academic impact, for papers by Coleen M. Atkins Breakdown of academic impact, for papers by Hiroshi Ujike